ANIP
ANI Pharmaceuticals Inc
Halal Rating :
Last Price
$58.52
Last updated:
Market Cap
-
7D Change
8.51%
1 Year Change
4.18%
Company Overview
Industries
Exchange
Next Earnings Date
ANI Pharmaceuticals Inc. is a diversified biopharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. The company focuses on niche and high-barrier-to-entry opportunities in the pharmaceutical sector, including controlled substances, oncology products, hormones and steroids, and complex formulations.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $148.33m | $176.32m | - | $7.47m | 0.00% | 4.24% |
| June 30, 2024 | $138.04m | $132.87m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $137.43m | $117.12m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate ANI Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.